← Back to Search

Air Filtration

Air Purification for Cardiovascular Health in Seniors (RAPIDS2-Ypsi Trial)

N/A

Recruiting

Led By Robert Brook, MD

Research Sponsored by University of Michigan

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

≥60 years old

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 4 weeks

Awards & highlights

RAPIDS2-Ypsi Trial Summary

This trial found that PM2.5 exposure is associated with an increased risk of CV events.

Who is the study for?

This trial is for seniors aged 60 or older living in Carpenter Place Apartments who don't smoke. Participants should not have had a cardiovascular event recently, be exposed to secondhand smoke daily, or have unstable heart conditions. They must also commit to not traveling overnight during the study and be on stable medication if they're being treated for high blood pressure, diabetes, or other heart issues.Check my eligibility

What is being tested?

The study tests whether using an air purifier with a HEPA filter can reduce health problems related to fine particulate matter (PM2.5) pollution in seniors with cardiometabolic syndrome compared to a sham (fake) device.See study design

What are the potential side effects?

Since this trial involves the use of an air purifier versus a sham device, there are no direct medical side effects expected from participating in this study.

RAPIDS2-Ypsi Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 60 years old or older.

RAPIDS2-Ypsi Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 4 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~4 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Systolic Blood Pressure

Secondary outcome measures

24-hr Blood Pressure

Aortic Hemodynamics

Atmospheric particulate matter (pm2.5)

+4 more

RAPIDS2-Ypsi Trial Design

2Treatment groups

Active Control

Placebo Group

Group I: air filtration with hepa filterActive Control1 Intervention

air purifier used is the Holmes HAP8650B-NU-1 with the hepa filter inserted.

Group II: air filtration with hepa filter removedPlacebo Group1 Intervention

sham comparator uses the Holmes HAP8650B-NU-1 air purifier to be operated with the filter removed.

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Michigan State UniversityOTHER

185 Previous Clinical Trials

601,972 Total Patients Enrolled

National Institute of Nursing Research (NINR)NIH

580 Previous Clinical Trials

10,376,506 Total Patients Enrolled

University of MichiganLead Sponsor

1,798 Previous Clinical Trials

6,378,083 Total Patients Enrolled

Media Library

Air Filtration with Air Purifier (Air Filtration) Clinical Trial Eligibility Overview. Trial Name: NCT04103346 — N/A

Cardiometabolic Syndrome Research Study Groups: air filtration with hepa filter, air filtration with hepa filter removed

Cardiometabolic Syndrome Clinical Trial 2023: Air Filtration with Air Purifier Highlights & Side Effects. Trial Name: NCT04103346 — N/A

Air Filtration with Air Purifier (Air Filtration) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04103346 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants is this trial accommodating?

"Affirmative. Data hosted on clinicaltrials.gov attests that this investigation, which was initially published on February 24th 2020, is actively seeking enrolment. Approximately 55 volunteers are necessary to be enrolled from 2 individual sites."

Answered by AI

Is it still feasible for individuals to be enrolled in this experiment?

"As of present, this clinical trial is actively recruiting volunteers. It was originally announced on February 24th 2020 and has experienced its most recent modification on May 19th 2022."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Reducing Particulate Matter-associated Cardiovascular Health Effects for Seniors

Geoffrey Barnes 2020. "Reducing Particulate Matter-associated Cardiovascular Health Effects for Seniors". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04103346.

All > Cardiovascular